CEVEC and VPM Sign Exclusive License Agreement

News   Jan 04, 2013

 
CEVEC and VPM Sign Exclusive License Agreement
 
 
 

RELATED ARTICLES

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

Vaccine to One Hemorrhagic Virus Could Protect Against Others

News

Scientists report that antibodies made in response to a vaccine against one hemorrhagic fever virus—Junin—can successfully disarm one of its cousins, Machupo, for which there’s currently no vaccine.

READ MORE

'Universal Antibodies' Disarm Various Pathogens

News

Based on the sugar structures on their surface, bacteria can be classified in subgroups. As a rule, an antibody eliminates only one subgroup and does not protect against other microbes. However, in studies with the bacterium Klebsiella pneumoniae, researchers have now been the first to find that the immune system also produces antibodies that recognize and neutralize various microorganisms.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE